anv-419
anaveon
['anv419', 'anv419 ', 'anaveon', 'aveo']
anaveon presents updated data from the phase i/ii study of anv419 during the esmo congress 2022 - anv419 is well-tolerated at high doses and demonstrates notable safety with strong pharmacodynamic effects and excellent il-2rbg selectivity - a phase i... 
CEO Of Digital Media Online